Stokes Family Office’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.66M | Buy |
25,110
+1,009
| +4% | +$187K | 0.49% | 52 |
|
|
2025
Q1 | $5.05M | Sell |
24,101
-2,991
| -11% | -$627K | 0.57% | 42 |
|
|
2024
Q4 | $4.81M | Buy |
27,092
+3,057
| +13% | +$543K | 0.51% | 47 |
|
|
2024
Q3 | $4.75M | Buy |
24,035
+209
| +0.9% | +$41.3K | 0.52% | 45 |
|
|
2024
Q2 | $4.09M | Buy |
23,826
+504
| +2% | +$86.4K | 0.48% | 51 |
|
|
2024
Q1 | $4.25M | Sell |
23,322
-490
| -2% | -$89.2K | 0.53% | 49 |
|
|
2023
Q4 | $3.69M | Sell |
23,812
-3,657
| -13% | -$567K | 0.5% | 50 |
|
|
2023
Q3 | $4.09M | Buy |
27,469
+116
| +0.4% | +$17.3K | 0.48% | 51 |
|
|
2023
Q2 | $3.69M | Buy |
27,353
+51
| +0.2% | +$6.87K | 0.43% | 53 |
|
|
2023
Q1 | $4.35M | Sell |
27,302
-689
| -2% | -$110K | 0.54% | 37 |
|
|
2022
Q4 | $4.52M | Buy |
27,991
+603
| +2% | +$97.5K | 0.58% | 42 |
|
|
2022
Q3 | $3.68M | Buy |
27,388
+381
| +1% | +$51.1K | 0.52% | 45 |
|
|
2022
Q2 | $4.14M | Sell |
27,007
-83
| -0.3% | -$12.7K | 0.56% | 42 |
|
|
2022
Q1 | $4.39M | Buy |
27,090
+531
| +2% | +$86.1K | 0.58% | 43 |
|
|
2021
Q4 | $3.6M | Buy |
26,559
+490
| +2% | +$66.3K | 0.45% | 53 |
|
|
2021
Q3 | $2.81M | Sell |
26,069
-128
| -0.5% | -$13.8K | 0.39% | 55 |
|
|
2021
Q2 | $2.95M | Buy |
26,197
+295
| +1% | +$33.2K | 0.42% | 52 |
|
|
2021
Q1 | $2.8M | Buy |
25,902
+915
| +4% | +$99.1K | 0.44% | 53 |
|
|
2020
Q4 | $2.68M | Buy |
24,987
+509
| +2% | +$54.5K | 0.53% | 47 |
|
|
2020
Q3 | $2.14M | Buy |
24,478
+932
| +4% | +$81.6K | 0.49% | 50 |
|
|
2020
Q2 | $2.31M | Buy |
23,546
+853
| +4% | +$83.8K | 0.58% | 46 |
|
|
2020
Q1 | $1.73M | Buy |
22,693
+1
| +0% | +$76 | 0.46% | 48 |
|
|
2019
Q4 | $2.01M | Buy |
+22,692
| New | +$2.01M | 0.45% | 49 |
|